Alnylam Pharmaceuticals (ALNY) Prepaid Assets (2009 - 2026)

Alnylam Pharmaceuticals (ALNY) has 18 years of Prepaid Assets data on file, last reported at $302.2 million in Q2 2026.

• Quarterly Prepaid Assets rose 105.12% year-over-year to $302.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $302.2 million (up 105.12% YoY) and the FY2025 annual result came in at $281.9 million, up 141.01% from the prior year.
• Prepaid Assets advanced to $302.2 million in Q2 2026, from $242.1 million in the prior quarter.
• In the past five years, Prepaid Assets ranged from a high of $302.2 million in Q2 2026 to a low of $115.1 million in Q1 2022.
• A 5-year average of $165.8 million and a median of $146.4 million in 2023 frame the typical range for Prepaid Assets.
• The widest YoY moves for Prepaid Assets: up 141.01% in 2025, down 24.53% in 2025.
• Tracing ALNY's Prepaid Assets over 5 years: stood at $132.9 million in 2022, then fell by 4.92% to $126.4 million in 2023, then decreased by 7.45% to $117.0 million in 2024, then surged by 141.01% to $281.9 million in 2025, then increased by 7.2% to $302.2 million in 2026.
• The last three Prepaid Assets figures came in at $302.2 million (Q2 2026), $242.1 million (Q1 2026), and $281.9 million (Q4 2025), per Business Quant data.